24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Conditions Treated Asbestosis Lung Cancer Pleural Effusions
specialties & services
As the clinical director of the Thoracic Oncology Gene Therapy Program, Dr. Daniel Sterman specializes in thoracic oncology, with an emphasis on malignant mesothelioma. Dr. Sterman graduated from Cornell University Medical College in 1989 and completed his residency at the University of Pennsylvania. He was a fellow at the same university. Dr. Sterman’s specialty is thoracic oncology, but his main area of focus has been mesothelioma and more effective treatments methods for quite a while. He has published several works, most relating to mesothelioma and the way it could be treated using human gene therapy. Dr. Daniel Sterman’s clinical trials have helped advance cancer treatments in the last few years.
Brown University - 1985
Education
Cornell University Medical College - 1989
Medical School
University of Pennsylvania
Residency
Hospital of the University of Pennsylvania
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Critical Care Medicine
American Board of Internal Medicine - Pulmonary Disease
Abramson Cancer Center Hospital University of Pennsylvania (HUP)
Languages: English/Spanish
(800) 789-7366
University of Pennsylvania, 3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104 
Penn Presbyterian Medical Center
Languages: English/Spanish
(215) 662-8000
51 N 39th St
Philadelphia, Pennsylvania 19104
Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma.
Sterman DH, Kaiser LR, Litzky LA, Albelda SM
See more >>
Pilot and feasibility trial of immuno-gene therapy of malignant mesothelioma using intrapleural delivery of adenovirus-interferon-alpha combined with chemotherapy
Sterman DH1, Alley E2, Stevenson JP2, Friedberg J3, Metzger S1, Recio A1, Moon EK1, Haas AR1, Vachani A1, Katz SI4, Sun J1, Heitjan DF5, Hwang WT5, Litzky L6, Yearley JH7, Tan KS5, Papasavvas E8, Kennedy P1, Montaner LJ8, Cengel KA9, Simone CB 2nd9, Culligan M3, Langer CJ2, Albelda SM10.
See more >>
Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.
Mayor, M.,Yang, N.,Sterman, D.,Jones, D. R.,Adusumilli, P. S.; Eur J Cardiothorac Surg.
See more >>
Hospitals & Clinics